TGF-β signaling may play a role in the development of goblet cell hyperplasia in a mouse model of allergic rhinitis

Allergology International

Volumn 59, Issue 3, 2010, Pages 313-319

  Ouyang, Yuhui ^a   Miyata, Masanori ^a   Hatsushika, Kyosuke ^a   Ohnuma, Yuko ^a   Katoh, Ryohei ^a   Ogawa, Hideoki ^b   Okumura, Ko ^b   Masuyama, Keisuke ^a   Nakao, Atsuhito ^a,b  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Allergic rhinitis; Epithelial cells; Smad; TGF

Indexed keywords

OVALBUMIN; PHOSPHOTRANSFERASE INHIBITOR; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CASE REPORT; CELL HYPERPLASIA; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GOBLET CELL; GOBLET CELL HYPERPLASIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NOSE MUCOSA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 77957221356     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.10-SC-0172     Document Type: Article

References (22)

1. International Rhinitis Management Working Group. International consensus report on the diagnosis and management of allergic rhinitis. Allergy 1994;49:5-34.
2. Malone DC, Lawson KA, Smith DH, Arrighi HM, Battista CA. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol 1997;99:22-7.
3. Baraniuk JN. Mechanisms of allergic rhinitis. Curr Allergy Asthma Rep 2001;1:207-17.
4. Massague J. The transforming growth factor-β family. Annu Rev Cell Biol 1990;6:597-641.
5. Heldin CH, Miyazono K, Ten Dijke P. TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 1997;390:465-71.
6. Attisano L, Wrana JL. Signal transduction by the TGF-β superfamily. Science 2002;296:1646-7.
7. Yingling JM, Blanchard KL, Sawyer JS. Development of TGF-β signalling inhibitors for cancer therapy. Nat Rev Drug Discov 2004;3:1011-22.
8. Salib RJ, Kumar S, Wilson SJ, Howarth PH. Nasal mucosal immunoexpression of the mast cell chemoattractants TGF-β, eotaxin, and stem cell factor and their receptors in allergic rhinitis. J Allergy Clin Immunol 2004;114: 799-806.
9. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGF-β activation. J Cell Sci 2003;116:217-24.
10. Ogasawara H, Asakura K, Saito H, Kataura A. Role of CD4-positive T cells in the pathogenesis of nasal allergy in the murine model. Int Arch Allergy Immunol 1999;118: 37-43.
11. Singh J, Chuaqui CE, Boriack-Sjodin PA et al. Successful shape-based virtual screening: the discovery of a potent inhibitor of the type I TGF-β receptor kinase. Bioorg Med Chem Lett 2003;13:4355-9.
12. Sakuma M, Hatsushika K, Koyama K et al. TGF-β type I receptor kinase inhibitor down-regulates rheumatoid synoviocytes and prevents the arthritis induced by type II collagen antibody. Int Immunol 2007;19:117-26.
13. Rosendahl A, Pardali E, Speletas M, Ten Dijke P, Heldin CH, Sideras P. Activation of bone morphogenetic protein/ Smad signaling in bronchial epithelial cells during airway inflammation. Am J Respir Cell Mol Biol 2002;27:160-9.
14. Sagara H, Okada T, Okumura K et al. Activation of TGF- β/Smad2 signaling is associated with airway remodeling in asthma. J Allergy Clin Immunol 2002;110:249-54.
15. Kariyawasam HH, Xanthou G, Barkans J, Aizen M, Kay AB, Robinson DS. Basal expression of bone morphogenetic protein receptor is reduced in mild asthma. Am J Respir Crit Care Med 2008;177:1074-81.
16. Thai P, Loukoianov A, Wachi S, Wu R. Regulation of airway mucin gene expression. Annu Rev Physiol 2008;70: 405-29.
17. Chu HW, Balzar S, Seedorf GJ et al. Transforming growth factor-β2 induces bronchial epithelial mucin expression in asthma. Am J Pathol 2004;165:1097-106.
18. McMillan SJ, Xanthou G, Lloyd CM. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-β antibody: effect on the Smad signaling pathway. J Immunol 2005;174:5774-80.
19. Leung SY, Niimi A, Noble A et al. Effect of transforming growth factor-b receptor I kinase inhibitor 2,4- disubstituted pteridine (SD-208) in chronic allergic airway inflammation and remodeling. J Pharmacol Exp Ther 2006; 319:586-94.
20. Le AV, Cho JY, Miller M, McElwain S, Golgotiu K, Broide DH. Inhibition of allergen-induced airway remodeling in Smad3-deficient mice. J Immunol 2007;178:7310-6.
21. Alcorn JF, Rinaldi LM, Jaffe EF et al. Transforming growth factor-β1 suppresses airway hyperresponsiveness in allergic airway disease. Am J Respir Crit Care Med 2007;176:974-82.
22. Salib RJ, Howarth PH. Transforming growth factor-β in allergic inflammatory disease of the upper airways: friend or foe? Clin Exp Allergy 2009;39:1128-35.